GLP1R and type 2 diabetes mellitus: However, an exclusive decrease in abundance was observed for Marvinbryantia in type 2 diabetes, for which a reduction in Marvinbryantia through treatment with glucagon-like peptide-1 receptor agonist drugs, such as liraglutide, has been shown to contribute to treatment success4.